“…(), patients with endometriosis may benefit from a sequential approach in which autophagy is selectively inhibited in endometriotic cells, diseased cells, and then selectively activated in endometrial cells, non‐diseased cells, after discontinuation of drug treatment. However, to date, only a few studies have investigated the role of autophagy in endometriosis, as well as in the endometrium, and the results remain controversial (Choi et al ., ; Allavena et al ., ; Mei et al ., ; Ruiz et al ., ; Liu et al ., ). Further studies are required to determine whether long‐term inhibition of autophagy prevents recurrence of endometriosis after discontinuation of drug treatment and whether it results in any adverse effects on the endometrium of patients with endometriosis.…”